The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their ...

Dr Alberto-Giovanni Busetto is a Swiss-Italian AI Executive & Innovator and the Chief AI Officer of HealthAI HealthAI. He is ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

A man with a long track record of corruption took office as president in January. In his second term, he's surrounding ...

“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week. (3/18) Here's today's health policy haiku: ...

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical ...

Rob Isbitts explains why current market volatility underscores the importance of understanding indexation and algorithmic ...

Kurt Gustafson; Chief Financial Officer, Executive Vice President - Finance; OmniAb Inc. Matthew Foehr; President, Chief Executive Officer, Director; OmniAb Inc. Joe ...

Federal funding for biomedical research pays off by enabling basic discoveries that lead to lifesaving treatments, writes ...

DelveInsight's Molecular Glues Market Insights report includes a comprehensive understanding of current treatment practices, emerging molecular glues, market share of individual therapies, and current ...